---
layout: single
title: "Business Trip Report - Korea @ Aug-2025"
date: Wed Dec 31 19:56:39 PST 2025
last_modified_at: Sun Jan  4 18:22:45 PST 2026
permalink: /report/biz-trip/2025/aug
categories:
 - report
tags:
 - business trip
toc: true
toc_label: "&nbsp;Table of Contents"
toc_icon: "fa-solid fa-music"
toc_sticky: true
author_profile: true
---

posted: {{ page.date| date: "%d-%b-%Y" }}
&amp;
updated: {{ page.last_modified_at| date: "%d-%b-%Y" }}
{: .notice--primary}

**Report prepared by** Sunghee Yun
<br>
**Initial draft on** 31-Dec-2025
<br>
**Final Revised on** 04-Jan-2026

# Trip Overview

**Korea â€¢ August 6-20, 2025 â€¢ Sunghee Yun**

Historic 14-night trip marking the official launch of Erudio Bio Korea, Inc. with Jin Young Heo as CLO.
During this trip, Sunghee
- secured critical SNUBH joint development partnership
- opened corporate bank account in Jeonbuk
- advanced Special R&D Zone application
- secured USD 140k angel investment.

# Basic Logistics

**Dates** - August 6-20, 2025 (14 nights)

**Flights**
- **Outbound** - United 893, SFO â†’ ICN (departed Aug 6 @ 10:40am PDT, arrived Aug 7 @ 3:00pm KST)
- **Return** - United 892, ICN â†’ SFO (departed Aug 20 @ 4:42pm KST, arrived Aug 20 @ 12:04pm PDT)

**Base** - Garak-dong, Seoul

**Regional Trips**
- **Aug 8** - Day trip to Jeonbuk & Daejeon
  - KTX 451: Gwangmyeong Station â†’ Iksan Station (7:55am â†’ 8:53am)
  - SRT 370: Daejeon Station â†’ Gwangmyeong Station (6:25pm â†’ 7:13pm)
- **Aug 12-13** - Overnight trip to Pohang (via Gyeongju)
  - SRT 321: Suseo Station â†’ Gyeongju Station (9:20am â†’ 11:26am)
  - SRT 370: Gyeongju Station â†’ Suseo Station (9:05pm â†’ 11:12pm)
- **Aug 19** - Day trip to Iksan
  - SRT 607: Suseo Station â†’ Iksan Station (10:35am â†’ 12:02pm)
  - SRT 614: Iksan Station â†’ Suseo Station (4:15pm â†’ 5:36pm)

# ACTION ITEMS

| Owner | Deliverable | Deadline | Status |
|-------|-------------|----------|--------|
| Jin Young Heo | Finalize Jeonbuk Special R&D Zone application documents | Sep-2025 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Jin Young Heo | Schedule & conduct SNUBH remote video meeting | Week of 25-Aug-2025 | <strong>Scheduled</strong> |
| Sunghee Yun / Jin Young Heo | Coordinate with BSR Korea on government grant applications (post-Special Zone designation) | Ongoing | <font color="red">Pending designation</font> |
| Sunghee Yun / Ghayougn Lee | Formalize SNUBH joint development agreement terms | Sep-2025 | <span style="color: blue;">In Progress</span>|
| Sunghee Yun | Follow up with POSTECH faculty on collaboration/advisory roles | Sep-2025 | <span style="color: red;">Pending</span> |

# MILESTONES & TIMELINE

**Immediate (Aug-Sep 2025):**
- âœ… Erudio Bio Korea, Inc. operational with Jin Young Heo as CLO
- âœ… Jeonbuk corporate bank account opened
- âœ… USD 140k angel investment secured
- ðŸ”„ SNUBH partnership terms finalized
- ðŸ”„ Jeonbuk Special R&D Zone application submitted

**Short-term (Q4 2025):**
- Jeonbuk Special R&D Zone designation decision
- SNUBH joint development project kickoff using residual specimens
- Government grant applications via BSR Korea (contingent on designation)

**Medium-term (2026):**
- Clinical data generation from SNUBH collaboration
- Productization and commercialization strategy refinement based on Jeonbuk officials' feedback

# STRATEGIC INSIGHTS

1. **Speed to Market:** Using SNUBH facilities and residual specimens eliminates 6+ months of setup time and regulatory complexity

2. **Government Support:** Jeonbuk Special R&D Zone designation unlocks significant grant funding, but requires strong commercialization narrative (not just R&D story)

3. **Partnership Model:** SNUBH's willingness to provide facilities demonstrates strong institutional commitment beyond typical collaboration

4. **Capital Efficiency:** USD 140k angel investment + potential government grants positions Korea entity for aggressive execution without heavy US dilution

5. **Organizational Structure:** Jin Young Heo as CLO/BD Manager provides critical local expertise for navigating Korean regulatory and government landscape

# KEY MEETINGS & OUTCOMES

## 07-Aug-2025 - Erudio Bio Korea Strategic Launch

<h3>Attendees</h3>

- Sunghee Yun
- Jin Young Heo (newly appointed CLO & BD Manager)

<h3>Core Messages</h3>

- First face-to-face strategic meeting since founding Erudio Bio Korea, Inc.
- Drafted application documents for Jeonbuk Special R&D Zone designation
- Planned Jeonbuk government engagement strategy

<h3>Purpose</h3>

Formalize Korea entity operations and government relations roadmap

## 08-Aug-2025 - Jeonbuk Special R&D Zone Officials Meeting

**Location** - Jeonbuk Special R&D Zone

<h3>Attendees</h3>

- **Erudio Bio**
	- Sunghee Yun
	- Jin Young Heo
- **BSR Korea**
	- Seungrak Baek (CEO)
	- Yujin Kim (Manager)
- **Government Officials**
  - Minseong Kang (Center Director, Jeonbuk Mutual Cooperation Research Center, National Institute of Toxicological Research)
  - Jihong Yoon (Team Leader, Technology Commercialization Team, Jeonbuk R&D Special Zone HQ)
  - Jonghak Won (Technology Commercialization Specialist, Jeonbuk R&D Special Zone HQ)

<h3>Core Messages</h3>

- Introduced Erudio Bio's VSA platform and bioTCAD vision to government stakeholders
- Officials emphasized need for clear commercialization and sales strategy post-productization

<h3>Discussion</h3>

Pathway to Jeonbuk Special Zone designation and available government support programs

<h3>Follow-up</h3>

BSR Korea office visit - presented AI seminar to employees, discussed government grant opportunities contingent on Special Zone selection

## 18-Aug-2025 - SNUBH Joint Development Partnership

**Location** - Seoul National University Bundang Hospital (SNUBH)

<h3>Attendees</h3>

- **Erudio Bio**
	- Sunghee Yun
	- Jin Young Heo
- **SNUBH**
  - Dr. Kiheon Lee (Professor, Family Medicine; Health Promotion Center Director)
  - Dr. Kyunghoon Lee (Laboratory Medicine)
  - Dr. Huikyung Han (Family Medicine)

<h3>CRITICAL DECISIONS MADE</h3>

- **Facilities** - Erudio Bio will use SNUBH facilities directly (eliminates need to rent separate office/lab)
- **Specimens** - Use residual specimens (ìž”ì—­ê²€ì²´) - no patient consent required, accelerates timeline
- **Next Steps** - Remote video meeting scheduled for following week (week of Aug 25)

<h3>Strategic Impact</h3>

Major cost savings, faster execution, simplified regulatory pathway

## 19-Aug-2025 - SNUBH Results Discussion - Internal

**Time** - 9:15am

<h3>Attendees</h3>

- Kee-hyun Paik
- Jin Young Heo
- Sunghee Yun
- Ghayoung Lee

<h3>Purpose</h3>

Align leadership on SNUBH partnership terms and execution plan

## 19-Aug-2025 - Opening Corporate Banking @ Jeonbuk

<h3>Action</h3>

Opened corporate bank account for Erudio Bio Korea, Inc. in Jeonbuk

<h3>Strategic Rationale</h3>

Establishes local presence for Special R&D Zone application

## 14-Aug-2025 - Internal HR Decision

<h3>Attendees</h3>
- Sunghee Yun
- Jin Young Heo
- Taeyoung Park (candidate)

<h3>Decision</h3>

After dinner discussion, Sunghee Yun and Jin Young Heo decided <span style="color: red; font-style:italic;">**not**</span> to extend offer to Taeyoung Park for Erudio Bio Korea role.

# FUNDRAISING

## 15-Aug-2025 - Secure angel investment

<h3>Outcome</h3>

**USD 140k investment secured**

# PARTNERSHIP

## 20-Aug-2025 - D.Notitia Partnership Discussion

<h3>Attendee</h3>

- **Erudio Bio**
	- Sunghee Yun
- **D.Notitia**
	- Junhyuk Son (COO/VP/Co-Founder)

**Purpose:** Explored potential partnership opportunities

# NETWORKING

## 13-Aug-2025 - POSTECH Networking Dinner

<h3>Attendees</h3>

- Sunghee Yun
- Prof. Yongjun Kim (Electrical Engineering, POSTECH)
- Prof. Namyoon Lee (Electrical Engineering, POSTECH)
- Prof. Gunsoo Yoon (Nuclear Engineering/Physics, POSTECH)
- Prof. Yunhak Baek (Yeungnam University)

<h3>Purpose</h3>

Explored collaboration and advisory opportunities with POSTECH faculty
